Candesartan vs Upadacitinib

Candesartan vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Candesartan and Upadacitinib.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6; Upadacitinib — C17H19F3N6O.

Molecular Weight: Candesartan — 610.6640 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Candesartan — Small molecule; Upadacitinib — Small molecule.